Announcement & Circular
Corporate Governance
Financial Results
IR Activities
Contact Us
Announcement & Circular
Stock Information
02186.HK
2.48 0.05  (2.06%)
TradingVolume：8036
03-14
2025
NOTICE OF BOARD MEETING
Publisher：
03-10
2025
LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION
Publisher：
03-10
2025
CHANGE OF NON-EXECUTIVE DIRECTOR
Publisher：
03-05
2025
Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2025
Publisher：
02-05
2025
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2025
Publisher：
01-15
2025
FIRST PATIENT ENROLLED FOR THE PHASE 2 CLINICAL STUDY OF THE GROUP'S NEW DRUG LY03015 IN CHINA
Publisher：
01-14
2025
APPROVAL OBTAINED FOR THE GROUP'S NEW DRUG LY03020 FOR CLINICAL TRIALS IN THE U.S.
Publisher：
01-02
2025
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2024
Publisher：
12-18
2024
INCREASE IN SHAREHOLDING IN THE COMPANY BY CONTROLLING SHAREHOLDER
Publisher：
12-16
2024
OVERSEAS REGULATORY ANNOUNCEMENT
Publisher：
First
1
2
3
4
5
Last
Investors
Announcement & Circular
Corporate Governance
Financial Results
IR Activities
Contact Us
Stock Information
02186.HK
TradingVolume：8036
2.48
0.05  (2.06%)
Announcement & Circular
03-14
2025
NOTICE OF BOARD MEETING
03-10
2025
LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION
03-10
2025
CHANGE OF NON-EXECUTIVE DIRECTOR
03-05
2025
Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2025
02-05
2025
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2025
01-15
2025
FIRST PATIENT ENROLLED FOR THE PHASE 2 CLINICAL STUDY OF THE GROUP'S NEW DRUG LY03015 IN CHINA
01-14
2025
APPROVAL OBTAINED FOR THE GROUP'S NEW DRUG LY03020 FOR CLINICAL TRIALS IN THE U.S.
01-02
2025
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2024
12-18
2024
INCREASE IN SHAREHOLDING IN THE COMPANY BY CONTROLLING SHAREHOLDER
12-16
2024
OVERSEAS REGULATORY ANNOUNCEMENT
First
1
2
3
4
5
Last